Marker Therapeutics, Inc. (MRKR) Social Stream
MARKER THERAPEUTICS INC (MRKR) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MARKER THERAPEUTICS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued May 16, 2022
The Trend in the Analyst Price Target
MRKR's average price target has moved down $4.5 over the prior 22 months.
MRKR reports an average of 486.85% for its upside potential over the past 91 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MRKR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
MRKR's average broker recommendation rating improved by 0.08 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MRKR as an investment opportunity.
- MRKR has a higher average analyst price target than 71.72% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, MARKER THERAPEUTICS INC's variance in analysts' estimates is lower than -673.78% of them.
- In the context of Healthcare stocks, MARKER THERAPEUTICS INC's number of analysts covering the stock is higher than 143.05% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MARKER THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 504.43% of them.
Stocks similar to MARKER THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AGLE, NMTR, and SYBX.
View All Top Stocks by Price Target
Is MRKR a Buy, Hold or Sell? See the POWR Ratings now!